Synthesis and biological evaluation of alkenyldiarylmethane HIV-1 non-nucleoside reverse transcriptase inhibitors that possess increased hydrolytic stability

被引:0
|
作者
Cullen, Matthew D. [1 ]
De Clercq, Erik [2 ]
Pannecouque, Christophe
Hartman, Tracy L. [3 ]
Buckheit, Robert W., Jr. [3 ]
Deng, Bo Liang [5 ]
Cushman, Mark [1 ,4 ]
机构
[1] Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA
[2] Katholieke Univ Leuven, Rega Inst Med Res, Johnson & Johnson Pharmaceut Res & Dev, B-3000 Louvain, Belgium
[3] Imquest Biosci Inc, Antiinfect Res, Frederick, MD 21704 USA
[4] Purdue Univ, Purdue Canc Ctr, W Lafayette, IN 47907 USA
[5] Nektar Therapeut, Huntsville, AL 35806 USA
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
72-MEDI
引用
收藏
页码:666 / 666
页数:1
相关论文
共 50 条
  • [21] Optimization of diarylamines as non-nucleoside inhibitors of HIV-1 reverse transcriptase
    Ruiz-Caro, J
    Basavapathruni, A
    Kim, JT
    Bailey, CM
    Wang, LG
    Anderson, KS
    Hamilton, AD
    Jorgensen, WL
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (03) : 668 - 671
  • [22] HIV-1 reverse transcriptase resistance to non-nucleoside inhibitors.
    Spence, RA
    Johnson, KA
    BIOPHYSICAL JOURNAL, 1996, 70 (02) : MP356 - MP356
  • [23] Focus on Chirality of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors
    Famiglini, Valeria
    Silvestri, Romano
    MOLECULES, 2016, 21 (02):
  • [24] Novel benzophenones as non-nucleoside reverse transcriptase inhibitors of HIV-1
    Chan, JH
    Freeman, GA
    Tidwell, JH
    Romines, KR
    Schaller, LT
    Cowan, JR
    Gonzales, SS
    Lowell, GS
    Andrews, CW
    Reynolds, DJ
    St Clair, M
    Hazen, RJ
    Ferris, RG
    Creech, KL
    Roberts, GB
    Short, SA
    Weaver, K
    Koszalka, GW
    Boone, LR
    JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (05) : 1175 - 1182
  • [25] Halolactones are potent HIV-1 non-nucleoside reverse transcriptase inhibitors
    Han, Xin
    Wu, Haoming
    Dong, Chune
    Tien, Po
    Xie, Wei
    Wu, Shuwen
    Zhou, Hai-Bing
    RSC ADVANCES, 2015, 5 (13): : 10005 - 10013
  • [26] Design, Synthesis, and Evaluation of Diarylpyridines and Diarylanilines as Potent Non-nucleoside HIV-1 Reverse Transcriptase Inhibitors
    Tian, Xingtao
    Qin, Bingjie
    Wu, Zhiyuan
    Wang, Xiaofeng
    Lu, Hong
    Morris-Natschke, Susan L.
    Chen, Chin Ho
    Jiang, Shibo
    Lee, Kuo-Hsiung
    Xie, Lan
    JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (23) : 8287 - 8297
  • [27] The synthesis of several tritiated non-nucleoside, HIV-1 reverse transcriptase inhibitors.
    Hamill, TG
    Brenner, NJ
    Eng, W
    Burns, HD
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 1998, 41 (04): : 319 - 327
  • [28] Synthesis and biological activity of new pyridone diaryl ether non-nucleoside inhibitors of HIV-1 reverse transcriptase
    Kennedy-Smith, Joshua J.
    Arora, Nidhi
    Billedeau, J. Roland
    Fretland, Jennifer
    Hang, Julie Q.
    Heilek, Gabrielle M.
    Harris, Seth F.
    Hirschfeld, Donald
    Javanbakht, Hassan
    Li, Yu
    Liang, Weiling
    Roetz, Ralf
    Smith, Mark
    Su, Guoping
    Suh, Judy M.
    Villasenor, Armando G.
    Wu, Jeffrey
    Yasuda, Dennis
    Klumpp, Klaus
    Sweeney, Zachary K.
    MEDCHEMCOMM, 2010, 1 (01) : 79 - 83
  • [29] Novel modifications in the alkenyldiarylmethane (ADAM) series of non-nucleoside reverse transcriptase inhibitors
    Casimiro-Garcia, A
    Micklatcher, M
    Turpin, JA
    Stup, TL
    Watson, K
    Buckheit, RW
    Cushman, M
    JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (23) : 4861 - 4874
  • [30] HIV-1 non-nucleoside reverse transcriptase inhibitor
    Lloyd, AW
    DRUG DISCOVERY TODAY, 1998, 3 (08) : 387 - 387